Basis: FMP quote market capitalization / revenue from four consecutive issuer fiscal quarters. Source: stored company filings and market data; unavailable inputs remain N/A.
The P/S ratio is N/A as of 2026-10-06T13:40:59.864Z.
Calculation as of: 2026-10-06T13:40:59.864Z.
Quote observation: 2026-10-06T13:39:40.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: a5b8a39003d923715743cc0d1a2c59dcf36f227505f31b08d3d275f4059bcabd
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
PS RATIO
N/A
Market Cap
$768.46M
PS Ratio
18.53
TTM Avg
12.05
3Y Avg
176.43
5Y Avg
968.45
Market Cap
$758.52M
PS Ratio
12856.30
TTM Avg
4690.70
3Y Avg
1617.75
5Y Avg
973.20
Market Cap
$751.75M
PS Ratio
N/A
TTM Avg
1076.18
3Y Avg
1003.10
5Y Avg
1003.10
| NAME | MARKET CAP | PS RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Attovia Therapeutics, Inc. (ATTO) | $777.12M | N/A | N/A | N/A | N/A |
| Geron Corporation (GERN)vs › | $773.03M | 3.78 | 4.98 | 1623.75 | 1489.80 |
| Lexicon Pharmaceuticals, Inc. (LXRX)vs › | $768.46M | 18.53 | 12.05 | 176.43 | 968.45 |
| Design Therapeutics, Inc. (DSGN)vs › | $765.10M | N/A | N/A | N/A | N/A |
| AdaptHealth Corp. (AHCO)vs › | $791.15M | 0.26 | 0.48 | 0.44 | 0.69 |
| Avalo Therapeutics, Inc. (AVTX)vs › | $758.52M | 12856.30 | 4690.70 | 1617.75 | 973.20 |
| Cytek Biosciences, Inc. (CTKB)vs › | $796.81M | 3.85 | 2.95 | 3.49 | 6.67 |
| Candel Therapeutics, Inc. (CADL)vs › | $751.75M | N/A | 1076.18 | 1003.10 | 1003.10 |
| Gyre Therapeutics, Inc. (GYRE)vs › | $804.39M | 6.74 | 6.23 | 9.08 | 36.05 |
| InMode Ltd. (INMD)vs › | $813.07M | 2.17 | 2.45 | 3.11 | 6.00 |
The four-quarter calculation detail is unavailable for this stored observation.
The current P/S calculation cannot be reconciled from the stored quote and revenue inputs.
These references are supplied through FMP. Full filing context identifiers and dimensional metadata are unavailable in the normalized feed.
P/S Ratio
N/A
Market Cap / Trailing Twelve-Month Revenue
PS Ratio = Market Cap / Revenue (TTM)
The price-to-sales ratio compares market capitalization to trailing revenue. It is useful for valuing companies with little or no earnings.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
